latest newsRead more...
17
Dec 2018Innovent and Incyte Announce Strategic Collaboration and Licensing Agreement for Three Clinical-stage Product Candidates in China
Innovent Biologics Inc and Incyte today announced that the companies through their respective subsidiaries have entered into a strategic collaboration agreement for three clinicalstage product candidates discovered and developed by Incytepemigatinib FGFR inhibitor itacitinib JAK inhibitor and parsaclisib PIK inhibitor Under the terms of the…
15
Dec 2018Astellas Acquires Potenza Therapeutics
Astellas Pharma Inc today announced that it exercised and closed on its exclusive option to acquire Potenza Therapeutics Inc Potenza on December US Eastern Time This acquisition marks the successful outcome of a collaboration agreement entered into in to build a portfolio of novel immunooncology…
14
Dec 2018AMAG Pharmaceuticals Enters Into Definitive Merger Agreement to Acquire Perosphere Pharmaceuticals
AMAG Pharmaceuticals Inc today announced it has entered into a definitive agreement to acquire Perosphere Pharmaceuticals Inc a private biopharmaceutical company Through this acquisition AMAG will acquire global rights to ciraparantag a next generation anticoagulant reversal agent further enhancing its development pipeline and leveraging AMAGs…
13
Dec 2018Almirall and X-Chem Announce Dermatology-Focused Drug Discovery Collaboration
XChem Inc a privately held biotechnology company applying its innovative drug discovery platform to the generation of novel small molecule therapeutics announced today a drug discovery partnership with Almirall SA Almirall to discover lead compounds for innovative and challenging targets with dermatology applications Under the…
13
Dec 2018Lilly and AC Immune Announce License and Collaboration Agreement
Eli Lilly and Company and AC Immune SA today announced that the two companies have signed a license and collaboration agreement to research and develop tau aggregation inhibitor small molecules for the potential treatment of Alzheimers disease AD and other neurodegenerative diseases The collaboration combines…
press releasesRead more...
17
Dec 2018Bridge Biotherapeutics Announces FDA Clearance of IND for its BBT-877, an Autotaxin Inhibitor for IPF
Bridge Biotherapeutics Inc a clinical stage biotech company headquartered in Seongnam South Korea and a tenant company of JLABSTMC in Houston Texas announced that the Investigational New Drug IND application…
16
Dec 2018Innovent and Incyte Announce Strategic Collaboration and Licensing Agreement for Three Clinical-stage Product Candidates in China
SUZHOU China Dec PRNewswire Innovent Biologics Inc Innovent HKEX and Incyte NASDAQINCY today announced that the companies through their respective subsidiaries have entered into a strategic collaboration agreement for three…
15
Dec 2018Orchard Therapeutics and SIRION Biotech Announce Licensing Agreement to Enhance Gene Therapy Manufacturing Efficiency
Orchard Therapeutics a leading commercialstage biopharmaceutical company dedicated to transforming the lives of patients with serious and lifethreatening rare diseases through innovative gene therapies and SIRION Biotech GmbH today announced…
14
Dec 2018Recognize Mental Health as First Public Health Challenge, Says Dr. Prakriti Poddar, at Launch of Poddar Wellness Ltd
Business Wire IndiaDr Prakriti Poddar Director Poddar Wellness Ltd and Dr Indu Bhushan CEO Ayushman Bharat during Lamp Lighting Mental health leader Dr Prakriti Poddar launched Poddar Wellness Ltd in…
14
Dec 2018With 72 Percent Employee Rating, Automobiles Is the Most Loved Sector to Work For: JobBuzz Workplace Index OND 2018 Report
Business Wire IndiaAutomobiles is one of the most preferred sectors for employment and for good reasons JobBuzz Workplace Index which tabulates the employee sentiments as comparable percentages revealed that most…
EventsRead more...
06-09
Jan 20199th ICBE—International Conference on Biomolecular Engineering
AIChE
Newport Beach Marriott Hotel & Spa
12-14
Jan 2019ICPSB 2019
International Journal of Pharma Medicine and Biological Sciences
Bella Vista Waterfront Langkawi
16-17
Jan 2019Pre-Filled Syringes & Injectable Drug Devices
SMi Group Ltd
Copthorne Tara Hotel
16-18
Jan 20199th Emirates Otorhinolaryngology Audiology and Communication Disorders Congress
MCI Middle East
Intercontinental Festival City
TOP ARTICLES
-
1
Programmable Nanodevices for Biomedical Application: From Science Fiction to Reality
Suppose a patient is suffering from a brain tumor and immediate surgery is required to keep him alive but the location of the tumor is very critical and normal ..
-
2
Identification of MicroRNAs and Their Targets in Cancer
Although our cells are well equipped with regulatory checkpoints transformation of normal cells to malignant cancerous cells often occurs as a genetic disease W..
-
3
Smart Nano-Enabled Drug Carrier in Combating Tumor Development and Progress
Introduction The worldwide report of mortality due to lethal disease cancer is common and progressive nowadays Although nanomedicine advances in tumor biolog..
-
4
Are you Ready for EU FMD?
With the deadline looming for enactment of EU FMD and US DSCSA Vikash Pushpraj Senior Vice President rfxcel explains how achieving compliance is about much more..
-
5
Life-style, Environment, and Lack of Prediabetes Diagnosis Fueling Diabetic Epidemic
Introduction For the past ten years ample evidence exists to suggest that what we eat and how we live determines how our body and genes behave A rapid rise i..
-
6
Cancer Stem Cell (CSC) Inhibitors
Cancer as a group of heterogeneous diseases very well known Unimaginable amounts of money and manhours have been spent in finding cure for this deadly disease H..
Knowledge Bank
-
Interviews
Merck
Staff Engineer, Manufacturing Science and Technology, South East Asia
Karen Chan is a process engineer at Merck Pte Ltd Chan has six years of experience in the biopharmaceutical industry and two years of experience in research development She provides technical support in areas such as process development troubleshoot..
-
Articles
MicroRNA (miRNA) in Nanostructure Lipid Carriers based Tumor Gene Therapy
Introduction MicroRNAs is a noncoded double stranded RNAs made of approximately of nucleotides disclosed in by Ambros and Ruvkun laboratories that has significant role in regulation of gene expression at post transcriptional level It has been identified that the noncoding region of mRNA is capable of providing targeting signals in RNA binding protein domain…
-
Research Insights
Clonal Evolutionary Analysis during HER2 Blockade in HER2-Positive Inflammatory Breast Cancer: A Phase II Open-Label Clinical Trial of Afatinib +/- Vinorelbine
Abstract Background Inflammatory breast cancer IBC is a rare aggressive form of breast cancer associated with HER amplification with high risk of metastasis and an estimated median survival of y We performed an openlabel singlearm phase II clinical trial ClinicalTrialsgov NCT to investigate the efficacy and safety of afatinib an irreversible ErbB family inhibitor alone and in combination with vinorelbine…
-
Case Studies
Rapid, Comprehensive, And Aff Ordable Mycobacterial Diagnosis With Whole-genome Sequencing: A Prospective Case Study
Abstract Background Slow and cumbersome laboratory diagnostics for Mycobacterium tuberculosis complex MTBC risk delayed treatment and poor patient outcomes Wholegenome sequencing WGS could potentially provide a rapid and comprehensive diagnostic solution In this prospective study we compare realtime WGS with routine MTBC diagnostic workflows Methods We compared…
-
Techno Trends
NRX 100 Helps to Treat Severe Bipolar Depression with Acute Suicidal Ideation & Behavior (ASIB)
NeuroRxs NRX the first oral drug targeting suicidal bipolar depression helps to treat severe bipolar depression with Acute Suicidal Ideation Behavior ASIB NRX is used for treatment of Severe Bipolar Depression with Acute Suicidal Ideation Behaviour after initial stabilisation with ketamine or other effective therapy NRX Dcycloserinelurasidone fixed dose combination is the first oral drug demonstrated in human volunteers to…
-
White Papers
Launching Global Clinical Trials—best Practices For Efficient And Cost-effective Translations: A Lionsbridge White Paper
Summary The target market for conducting global clinical trials has changed significantly moving beyond pharmaceutical early adopters to the mainstream marketplace This shift has placed a heightened focus on the language challenges and complexity of running a global clinical trial More and more companies are moving toward ascending regions such as India and China to…
-
Industry Reports
Sanochemia Pharmazeutika AG (SAC) - Financial and Strategic SWOT Analysis Review
Sanochemia Pharmazeutika AG Sanochemia is a specialty pharmaceutical company that develops and manufactures of innovative drugs and diagnostics in selected indication areas such as neurodegeneration pain and cancer as well as diagnostic products based on contrast media The companys product portfolio includes radiological products including an array of xray imaging…
Advisory Board
Editorial Section
-
Strategy
Statin Drug Interactions and Related Adverse Reactions
Statins are generally well tolerated with a low frequency of adverse events but since statins are prescribed on a longterm basis many patients will typically receive pharmacological therapy for concomitant conditions during the course of statin treatment and potentially interacting…
-
Research development
Stem Cell and Gene Delivery
These days gene and stem cell therapies have the potential to make the substantial impact on the treatment of several diseases However there are pros and cons of each strategy but the optimal selection of gene delivery vector or stem…
-
Clinical Trials
Managing Clinical Trial Agreements
Clinical Trial Agreements set out how a clinical trial will be run at the site and are an essential GCP document There are a number of key factors that determine whether a Clinical Trial Agreement is successful in achieving that…
-
Manufacturing
Drug Concentration Assurance of Continuous Tablet Manufacturing
In the pharmaceutical industry Real Time Release RTR can be facilitated by the development of a highly efficient control system The drug concentration in final tablet is one of the most critical quality attributes that…
-
Information Technology
R&D DATA HUB
Faster decision making and better trial oversight at all levels requires truly next generation data integration and analytics Source and format agnostic data aggregation aided by modern data lake architecture and advanced analytics deliver interactive…